Quarterly report pursuant to Section 13 or 15(d)

NON CONTROLLING INTEREST (Details)

v3.21.1
NON CONTROLLING INTEREST (Details) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Net loss attributable to the non-controlling interest $ (776) $ (11,626)
BioCorRx Pharmaceuticals, Inc [Member]    
Net loss (3,207) (48,039)
Net loss attributable to the non-controlling interest $ (776) $ (11,626)
Average Non-controlling interest percentage of profit/losses 24.20% 24.20%